C12P 21 - Preparation of peptides or proteins

Patents for C12P 21 - Preparation of peptides or proteins (112,499)
12/2006
12/21/2006	US20060286631 Method for preparating t-20 peptide by high cell density cultivation of recombinant e. coli containing t-20 peptide coding gene
12/21/2006	US20060286630 Posh interacting proteins and related methods
12/21/2006	US20060286629 Methionine aminopeptidase enzymes; Wild-type Escherichia coli Met-AP; applying Qcyclase to the a peptide followed by purification on a cation exchange column
12/21/2006	US20060286605 Calcium biosensor polypeptides and methods of use
12/21/2006	US20060286597 Aortic carboxypeptidase-like polypeptide
12/21/2006	US20060286593 Transforming Growth Factor Alpha HI
12/21/2006	US20060286592 Increased ability to convert 5-fluorocytosine prodrug to its toxic form
12/21/2006	US20060286584 Compositions and methods for the regulation of cell proliferation and apoptosis
12/21/2006	US20060286124 Vaccine compositions and methods of treating coronavirus infection
12/21/2006	US20060286122 Modulation of angiogenesis by Bartonella henselae
12/21/2006	US20060286119 Compositions and methods for treatment of chronic and infectious diseases
12/21/2006	US20060286115 Preventive cancer vaccine based on brother of regulator of imprinted sites molecule
12/21/2006	US20060286114 Synthetic gene encoding rhesus monkey carcinoembryonic antigen and uses thereof
12/21/2006	US20060286113 single domain antibody AFAI; binds to non-small cell lung carcinoma; kits
12/21/2006	US20060286112 Human monoclonal antibodies that bind to very late antigen-1 for the treatment of inflammation and other disorders
12/21/2006	US20060286110 Bax-responsive genes for drug target identification in yeast and fungi
12/21/2006	US20060286107 Parathyroid hormone antibodies and related methods
12/21/2006	US20060286104 Superagonistic anti-CD28 antibodies
12/21/2006	US20060286102 Cell surface receptor isoforms and methods of identifying and using the same
12/21/2006	US20060286093 secreted tumor necrosis factor receptor polypeptides; modulates B cell activation; inhibiting ztnf4 activity
12/21/2006	US20060286091 RelA-ASSOCIATED INHIBITOR, PROCESS FOR PRODUCING THE SAME AND UTILIZATION THEREOF
12/21/2006	US20060286087 Recombinant alpha-L-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof
12/21/2006	US20060286035 Methods and compositions for modulating the interaction between adiponectin and its receptor
12/21/2006	US20060286031 Modulators of tissue regeneration
12/21/2006	CA2612168A1 Methods for producing antibodies
12/21/2006	CA2611502A1 A composition for wound healing and use thereof
12/21/2006	CA2611054A1 Novel a.beta.-binding protein and its peptide derivatives and uses thereof
12/21/2006	CA2611048A1 Psp94 diagnostic reagents and assays
12/20/2006	EP1734366A2 New method for the detection of acid-resistant micro-organisms in stool
12/20/2006	EP1734133A2 Heparanase specific molecular probes and their use in research and medical applications
12/20/2006	EP1734124A1 Prostate specific antigen peptides and uses thereof
12/20/2006	EP1734122A2 APO-2 ligand
12/20/2006	EP1734121A2 Genetically engineered human-derived Kunitz domains that inhibit human neutrophil elastase
12/20/2006	EP1734120A2 Reagents and methods for identifying and modulating expression of genes regulated by CDK inhibitors
12/20/2006	EP1734054A2 Anti-human thymidylate synthase monoclonal antibody and hybridoma capable of producing the same
12/20/2006	EP1734053A2 Monoclonal antibodies that recognize flk-2 receptors and the isolation of primitive hematopoietic stem cell populations
12/20/2006	EP1734051A2 Composition and methods for the diagnosis of tumours
12/20/2006	EP1733736A2 Method of producing recombinant antibodies against tumours
12/20/2006	EP1733041A2 Anti-myostatin antibodies
12/20/2006	EP1733040A2 Filamentous fungal mutants with improved homologous recombination efficiency
12/20/2006	EP1733039A2 Improved bacterial host cell for the direct expression of peptides
12/20/2006	EP1733037A2 Process for producing polypeptides
12/20/2006	EP1733034A2 Methods and constructs for expressing polypeptide multimers in eukaryotic cells using alternative splicing
12/20/2006	EP1732948A2 Therapeutic synergy of anti-cancer compounds
12/20/2006	EP1732946A2 Dimeric fusion proteins and materials and methods for producing them
12/20/2006	EP1732940A2 METHOD FOR CONSTRUCTION AND USE OF <i>KLUYVEROMYCES LACTIS</i> PROMOTER VARIANTS IN <i>K.LACTIS</i> THAT SUBSTANTIALLY LACK <i>E. COLI</i> TRANSCRIPTIONAL CAPABILITY
12/20/2006	EP1687421A4 A process for producing exogenous protein in the milk of trangenic mammals and a process for purifying proteins therefrom
12/20/2006	EP1578949A4 Site specific incorporation of keto amino acids into proteins
12/20/2006	EP1321473B1 Method for preventing a freeze-induced decrease of the activity of a protein
12/20/2006	EP1317537B1 G-csf analog compositions and methods
12/20/2006	EP1194164B1 Prion protein peptides and uses thereof
12/20/2006	EP1147123B1 Novel odorant receptors in drosophila
12/20/2006	EP1135477B1 Humanized monoclonal integrin antibodies
12/20/2006	EP0942983B1 Streptococcus pneumoniae antigens and vaccines
12/20/2006	CN1882685A A process for producing exogenous protein in the milk of trangenic mammals and a process for purifying proteins therefrom
12/20/2006	CN1882683A Microbe capable of producing dipeptide and process for producing dipeptide with the microbe
12/20/2006	CN1882359A Pharmaceutical compositions for therapeutic use
12/20/2006	CN1880451A Method for preparing recombinant aprotinin
12/20/2006	CN1880447A Process for preparing high-flux monoclonal antibody
12/20/2006	CN1880335A Monoclonal antibody for resisting human myeloblast differentiation marker gene and its uses
12/20/2006	CN1880334A High purity albumin production process
12/20/2006	CN1291032C Enzymolysis method for preparing protein oligopeptide powder using Pacific Ocean alaska pollack
12/20/2006	CN1291031C Method for preparing recombinant thymosin alpha 1
12/20/2006	CN1291019C Novel natural antibacterial peptide HKABF and its preparation and application
12/20/2006	CN1291015C Method for the recombinant production and purification of protein kinases
12/20/2006	CN1291012C Altered strain of modified vaccinia virus ankara (MVA)
12/20/2006	CN1290861C New type human bone marrow stroma cell source 1 type phosphatase inhibition factor, its coded sequence and use
12/19/2006	US7151172 virion infectivity factor (vif) proteins; use in vaccine against the HIV-1 virus
12/19/2006	US7151170 BNM (for Brassica napus microspore embryo); encodes a protein that renders plant cells embryongenic, and increases the regenerative capacity of the plant cell; producing asexually-derived embryos for example
12/19/2006	US7151169 For therapy of fibrosis, immune responses and tumor progression, asthma
12/19/2006	US7151168 Induction, controlling gene expression; genetic engineered plants
12/19/2006	US7151164 Genetic engineered, chimera and human monoclonal antibodies that bind to lymphocytes CD antigens, used for diagnosis and prohylaxis of cancer and autoimmune diseases
12/19/2006	US7151162 Capable of interacting with wnt-signalling pathway (beta-catenins and T-cell factors); cancer diagnosis
12/19/2006	US7151161 amino acid sequences; related to high bone density; possible use in treatment, diagnosis of osteoporosis
12/19/2006	US7151160 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/19/2006	US7151159 Amino acid sequences for therapeutic and prophylactic use against diseases due to clostridium difficile toxins
12/19/2006	US7151120 Generation of porous apparatus; obtain degradable porous material, mix in solvent, gel, recover porous apparatus
12/19/2006	US7151086 Bone morphogenetic protein (BMP)-17 and BMP-18 compositions
12/19/2006	US7150983 Modified proteolytic enzyme for treatment of osteoarthritis
12/19/2006	US7150979 Nucleotide sequences coding polypeptide for use as diagnostic tools genetic engineering
12/19/2006	US7150978 Transcription/translation; high throughput screening; genomics; proteomics
12/19/2006	US7150973 Methods and kits for purifying his-tagged proteins
12/19/2006	US7150875 Recombinant Plasmodium vivax merozoite protein-1 p42 vaccine
12/19/2006	US7150873 Hydrophilic eimeria polypeptide; genetic engineering
12/19/2006	US7150872 Chemical modification of single chain polypeptides by means of covalent attachment of strands of polyethylene glycol to single chain polypeptide binding molecules that have three dimensional folding and binding ability
12/19/2006	US7150871 Treatment of acute lung injury, fibrosis and metastasis with antagonists of αvβ6
12/19/2006	CA2200423C Novel estrogen receptor
12/14/2006	WO2006133333A2 Stimulation of pancreatic b cell proliferation
12/14/2006	WO2006133210A2 Mannitol induced promoter systems in bacterial host cells
12/14/2006	WO2006132969A2 Incorporation of non-naturally encoded amino acids into proteins
12/14/2006	WO2006132389A1 Nucleic acid, amino acid encoded by the nucleic acid, probe comprising the nucleic acid or the amino acid, and screening method using the probe
12/14/2006	WO2006132272A1 Method for production of antibody
12/14/2006	WO2006132248A1 Method for ubiquitination of runx
12/14/2006	WO2006131643A2 Method for enriching lignocellulose residues with yeast protein
12/14/2006	WO2006131586A1 Bioactive peptides identified in enzymatic hydrolyzates of milk caseins and method of obtaining same
12/14/2006	WO2006105486A3 Novel tumor suppressor gene and compositions and methods for making and using the same
12/14/2006	WO2006074409A9 Tripeptide and tetrapeptide sulfones
12/14/2006	WO2006036772A3 Crystallization of membrane proteins in three-dimentionally connected lipid bilayer gels
12/14/2006	US20060282917 Modified starch, uses, methods for production thereof
12/14/2006	US20060282908 Identification of the genetic determinants of the polymorphic CYP3A5 expression

1 ... 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 ... 1125